Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1213434

Adopting AMSTAR 2 critical appraisal tool for systematic reviews: speed of the tool uptake and barriers for its adoption


Bojčić, Ružica; Todorić, Mate; Puljak, Livia
Adopting AMSTAR 2 critical appraisal tool for systematic reviews: speed of the tool uptake and barriers for its adoption // BMC Medical Research Methodology, 22 (2022), 1; 1-9 doi:10.1186/s12874-022-01592-y (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 1213434 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Adopting AMSTAR 2 critical appraisal tool for systematic reviews: speed of the tool uptake and barriers for its adoption

Autori
Bojčić, Ružica ; Todorić, Mate ; Puljak, Livia

Izvornik
BMC Medical Research Methodology (1471-2288) 22 (2022), 1; 1-9

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
quality ; research methodology

Sažetak
Background In 2007, AMSTAR (A MeaSurement Tool to Assess systematic Reviews), a critical appraisal tool for systematic reviews (SRs), was published, and it has since become one of the most widely used instruments for SR appraisal. In September 2017, AMSTAR 2 was published as an updated version of the tool. This mixed-methods study aimed to analyze the extent of the AMSTAR 2 uptake and explore potential barriers to its uptake. Methods We analyzed the frequency of AMSTAR or AMSTAR 2 use in articles published in 2018, 2019 and 2020. We surveyed authors who have used AMSTAR but not AMSTAR 2 in the analyzed time frame to identify their reasons and barriers. The inclusion criterion for those authors was that the month of manuscript submission was after September 2017, i.e. after AMSTAR 2 was published. Results We included 871 studies. The majority (N = 451 ; 52%) used AMSTAR 2, while 44% (N = 382) used AMSTAR, 4% (N = 31) used R-AMSTAR and others used a combination of tools. In 2018, 81% of the analyzed studies used AMSTAR, while 16% used AMSTAR 2. In 2019, 52% used AMSTAR, while 44% used AMSTAR 2. Among articles published in 2020, 28% used AMSTAR, while AMSTAR 2 was used by 69%. An author survey indicated that the authors did not use AMSTAR 2 mostly because they were not aware of it, their protocol was already established, or data collection completed at the time when the new tool was published. Barriers towards AMSTAR 2 use were lack of quantitative assessment, insufficient awareness, length, difficulties with a specific item. Conclusion In articles published in 2018- 2020, that were submitted to a journal after AMSTAR 2 tool was published, almost half of the authors (44%) still used AMSTAR, the old version of the tool. However, the use of AMSTAR has been declining in each subsequent year. Our survey indicated that editors and peer-reviewers did not ask the authors to use the new version of the tool. Few barriers towards using AMSTAR 2 were identified, and thus it is anticipated that the use of the old version of AMSTAR will continue to decline.

Izvorni jezik
Engleski

Znanstvena područja
Javno zdravstvo i zdravstvena zaštita



POVEZANOST RADA


Ustanove:
KBC Split,
Medicinski fakultet, Split,
Hrvatsko katoličko sveučilište, Zagreb

Profili:

Avatar Url Livia Puljak (autor)

Poveznice na cjeloviti tekst rada:

doi bmcmedresmethodol.biomedcentral.com

Poveznice na istraživačke podatke:

bmcmedresmethodol.biomedcentral.com

Citiraj ovu publikaciju:

Bojčić, Ružica; Todorić, Mate; Puljak, Livia
Adopting AMSTAR 2 critical appraisal tool for systematic reviews: speed of the tool uptake and barriers for its adoption // BMC Medical Research Methodology, 22 (2022), 1; 1-9 doi:10.1186/s12874-022-01592-y (međunarodna recenzija, članak, znanstveni)
Bojčić, R., Todorić, M. & Puljak, L. (2022) Adopting AMSTAR 2 critical appraisal tool for systematic reviews: speed of the tool uptake and barriers for its adoption. BMC Medical Research Methodology, 22 (1), 1-9 doi:10.1186/s12874-022-01592-y.
@article{article, author = {Boj\v{c}i\'{c}, Ru\v{z}ica and Todori\'{c}, Mate and Puljak, Livia}, year = {2022}, pages = {1-9}, DOI = {10.1186/s12874-022-01592-y}, keywords = {quality, research methodology}, journal = {BMC Medical Research Methodology}, doi = {10.1186/s12874-022-01592-y}, volume = {22}, number = {1}, issn = {1471-2288}, title = {Adopting AMSTAR 2 critical appraisal tool for systematic reviews: speed of the tool uptake and barriers for its adoption}, keyword = {quality, research methodology} }
@article{article, author = {Boj\v{c}i\'{c}, Ru\v{z}ica and Todori\'{c}, Mate and Puljak, Livia}, year = {2022}, pages = {1-9}, DOI = {10.1186/s12874-022-01592-y}, keywords = {quality, research methodology}, journal = {BMC Medical Research Methodology}, doi = {10.1186/s12874-022-01592-y}, volume = {22}, number = {1}, issn = {1471-2288}, title = {Adopting AMSTAR 2 critical appraisal tool for systematic reviews: speed of the tool uptake and barriers for its adoption}, keyword = {quality, research methodology} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font